Quarterly Result20 May 2026, 02:37 pm
IOL Chemicals: Audited FY26 Results Approved, AGM on Sept 2
AI Summary
IOL Chemicals & Pharmaceuticals Ltd's board approved the audited standalone and consolidated financial results for the year ended March 31, 2026. The audit reports, issued by Ashwani & Associates, Chartered Accountants, contained an unmodified opinion. The 39th Annual General Meeting is scheduled for September 2, 2026, via video conferencing. The company also approved the installation of a plant for manufacturing Triacetin (6000 MTPA capacity in Phase-I) and enhanced the installed capacity of Pantoprazole from 240 MTPA to 276 MTPA, funded through internal accruals.
Key Highlights
- Audited Standalone & Consolidated Financial Results for FY26 approved.
- 39th AGM scheduled for September 2, 2026, via video conferencing.
- New Triacetin plant (6000 MTPA Phase-I) approved, funded internally.
- Pantoprazole capacity expansion to 276 MTPA approved, funded internally.
- Auditors issued unmodified opinion on FY26 financial statements.
Price Impact
More from IOLCP